Biological Medications / Plasma / Insulin


Full Tech Transfer and localization of Bio-Pharmaceutical medications.




Opportunity Highlights

  • Expected Investment size of USD (1.8 Billion for the whole segment and not capex / plant ( - capex/ plant is 375 Million)
  • Plant capacity: Subjected to review ktpa
  • Expected IRR: -Subjected to review %
  • Payback period: Subjected to review years
  • Job Creation: 330 till 2035 (Source NIS)
  • GDP Impact: Subjected to review %


Download the full Opportunity Here

contact our Biological Medications / Plasma / Insulin Expert

Thank you for your interest in the Invest Saudi.

We received your inquiry, and we will get back to you shortly.

Explore Other Sectors